Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy
NCT02911311
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
226
Enrollment
OTHER
Sponsor class
Conditions
Proliferative Diabetic Retinopathy
Interventions
DRUG:
intravitreal injection of conbercept
DEVICE:
PRP
Sponsor
Sun Yat-sen University